Do academic scientists bring valuable human capital to the companies they found or join? If so, what are the particular skills that compose their human capital and how are these skills related to firm performance? This paper examines these questions using a particular group of academic...

Do academic scientists bring valuable human capital to the companies they found or join? If so, what are the particular skills that compose their human capital and how are these skills related to firm performance? This paper examines these questions using a particular group of academic...

The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make different efforts to overcome shortcomings and recent gaps. Public funding schemes have been implemented to establish a flourish biotech industry in Germany. We assume that R&D policy...

This research investigates the hypothesis that publicly funded scientific research complements private R&D investment in the pharmaceutical industry. New microlevel data on public research investment by the U.S. National Institutes of Health allow measures of basic and clinical research in seven...

Dieser Beitrag zeigt auf Basis einer Befragung von Führungskräften eines internationalen Konzerns, unter welchen Bedingungen eine erfolgsabhängige Vergü-tung einen positiven Motivationseffekt erzielen kann. Neben einer positiven Ent-wicklung der Bonusauszahlung können weitere Faktoren die...

While most economists believe that public scientific research fuels industry innovation and economic growth, systematic evidence supporting this relationship is surprisingly limited. In a recent study, Acemoglu and Linn (2004) identified market size as a significant driver of drug innovation in...

While most economists believe that public scientific research fuels industry innovation and economic growth, systematic evidence supporting this relationship is surprisingly limited. In a recent study, Acemoglu and Linn (2004) identified market size as a significant driver of drug innovation in...

The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make different efforts to overcome shortcomings and recent gaps. Public funding schemes have been implemented to establish a flourish biotech industry in Germany. We assume that R&D policy...

Dieser Beitrag zeigt auf Basis einer Befragung von Führungskräften eines internationalen Konzerns, unter welchen Bedingungen eine erfolgsabhängige Vergü-tung einen positiven Motivationseffekt erzielen kann. Neben einer positiven Ent-wicklung der Bonusauszahlung können weitere Faktoren die...